What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?

被引：0
|
作者：
Muhammad Shahzeb Khan
Muthiah Vaduganathan
机构：
[1] Cook County Health and Hospital System,Department of Medicine
[2] Brigham and Women’s Hospital Heart & Vascular Center and Harvard Medical School,Heart and Vascular Center
来源：
Current Diabetes Reports | 2020年 / 20卷
关键词：
Antihyperglycemic therapies; Diabetes mellitus; Heart failure; SGLT-2 inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Eligibility of sodium-glucose co-transporter-2 inhibitors among patients with diabetes mellitus admitted for heart failure
    Sharma, Abhinav
    Wu, Jingjing
    Ezekowitz, Justin A.
    Felker, Gary Michael
    Udell, Jacob A.
    Heidenreich, Paul A.
    Fonarow, Gregg C.
    Mahaffey, Kenneth W.
    Hernandez, Adrian F.
    DeVore, Adam D.
    [J]. ESC HEART FAILURE, 2020, 7 (01): : 275 - 279
  • [22] Mineralocorticoid receptor antagonists with sodium-glucose co-transporter-2 inhibitors in heart failure: a meta-analysis
    Banerjee, Mainak
    Maisnam, Indira
    Pal, Rimesh
    Mukhopadhyay, Satinath
    [J]. EUROPEAN HEART JOURNAL, 2023, 44 (37) : 3686 - 3696
  • [23] Sodium-glucose co-transporter-2 inhibitors and protection from cardiovascular death: Is it all about heart failure?
    Caruso, Irene
    Cignarelli, Angelo
    Laviola, Luigi
    Giorgino, Francesco
    [J]. DIABETES OBESITY & METABOLISM, 2021, 23 (09): : 2194 - 2196
  • [24] Sodium-glucose co-transporter 2 inhibitors and acute heart failure
    Groenewegen, Amy
    Rutten, Frans H.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (04) : 723 - 725
  • [25] Comment on Sodium-Glucose Co-Transporter 2 Inhibitors and Heart Failure
    Cure, Erkan
    Cure, Medine Cumhur
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (10): : 1602 - 1602
  • [26] RENAL EFFECTS OF SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS IN PATIENTS WITH HEART FAILURE WITH REDUCED OR PRESERVED EJECTION FRACTION
    Patoulias, Dimitrios
    Katsimardou, Alexandra
    Boulmpou, Aristi
    Siskos, Fotios
    Imprialos, Konstantinos
    Stavropoulos, Konstantinos
    Zografou, Ioanna
    Papadopoulos, Christodoulos
    Doumas, Michael
    [J]. JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL 1) : E70 - E70
  • [27] Sodium-glucose co-transporter-2 inhibitors in heart failure with reduced ejection fraction: Current evidence and future perspectives
    Jensen, Jesper
    Omar, Massar
    Kistorp, Caroline
    Gustafsson, Finn
    Kober, Lars
    Moller, Jacob Eifer
    Schou, Morten
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2022, 131 (01) : 5 - 17
  • [28] Effect of Sodium-Glucose Co-transporter-2 Inhibitors on Ventricular Repolarization Markers in Heart Failure with Reduced Ejection Fraction
    Yilmaz, Emre
    Aydin, Ertan
    Camci, Sencer
    Kurt, Devrim
    Aydin, Ercan
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2024, 38 (02) : 327 - 333
  • [29] Effect of sodium-glucose co-transporter-2 inhibitors in haemoglobin level of patients with heart failure with reduced ejection fraction
    Catarina Carvalho, C.
    Carvalho, P.
    Bernardo, M.
    Moreira, I.
    Baptista, A.
    Moreira, I.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 166 - 167
  • [30] Renal effects of sodium-glucose co-transporter-2 inhibitors in patients with heart failure with reduced or preserved ejection fraction
    Patoulias, Dimitrios
    Papadopoulos, Christodoulos
    Karagiannis, Asterios
    Doumas, Michael
    [J]. NEFROLOGIA, 2024, 44 (04): : 584 - 585
12345